Navigation Links
Nuvelo Announces Positive Phase 1b Proof-of-Concept Data With Anticoagulant NU172
Date:8/14/2008

ffinity, and the ability to target protein-protein interactions.

NU172 is an aptamer designed to directly inhibit thrombin's ability to stimulate blood clot formation in the setting of medical procedures where human blood is exposed to foreign materials. Specifically, NU172 is being studied for use as a potential short-acting anticoagulant during procedures such as coronary artery bypass graft surgery, kidney dialysis and percutaneous coronary interventions. Data from the Phase 1 trial and preclinical studies suggest that NU172 has the potential to produce rapid and predictable onset and offset of anticoagulation, work in stagnant blood, avoid thrombocytopenia, and has the potential for non-renal clearance.

About Nuvelo and Archemix's Joint Collaborative Effort

In August 2006, Nuvelo expanded its collaboration with Archemix to develop and commercialize aptamers that have a short-acting anticoagulant effect. Under the agreement, Archemix is responsible for discovery of short-acting aptamers for use in medical procedures, and Nuvelo leads development and worldwide commercialization of these aptamers.

About Nuvelo

Nuvelo, Inc. is dedicated to improving the lives of patients through the discovery, development and commercialization of novel drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. Nuvelo's development pipeline includes NU172, a direct thrombin inhibitor which has completed Phase 1 development for use as a potential short-acting anticoagulant during medical or surgical procedures; and NU206, a Wnt pathway modulator in Phase 1 development for the potential treatment of chemotherapy/radiation therapy-induced mucositis and inflammatory bowel disease. In addition, Nuvelo is pursuing research programs in leukemia and lymphoma therapeutic antibodies and Wnt signaling pathway therapeutics to further expand its pipeline and create additional partnering and licensing opportunities.

Informati
'/>"/>

SOURCE Nuvelo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Initiates Phase 1B Clinical Trial of Anticoagulant NU172
2. Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172
3. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
4. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development
5. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
6. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
7. Nuvelo Announces Alfimeprase SONOMA-2 Catheter Occlusion Data Presentation Webcast and Conference Call
8. Nuvelo Re-Initiates SONOMA-3 Trial of Alfimeprase in Patients With Catheter Occlusion
9. NewCardio Announces Positive Results From Third Clinical Validation Study
10. Medarex Announces Initiation of Phase 2 Clinical Development Program for the Treatment of Lupus
11. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Fenwal Inc., a global leader focused on improving ... its commitment to provide blood centers with Alyx® system ... new lawsuit filed yesterday against Fenwal by Haemonetics Corporation ... 2003, is an advanced medical instrument used worldwide to ... donor in about 30 minutes. ,, Fenwal ...
(Date:12/15/2009)... West Pharmaceutical Services, Inc. (NYSE: WST ) ... payment of the first-quarter 2010 cash dividend of $0.16 ... 3, 2010 to shareholders of record on January 20, ... is a global manufacturer of components and systems for ... and closures and disposable components used in syringe, IV ...
(Date:12/15/2009)... Calif., Dec. 15 Dakim, Inc. and Alzheimer,s ... for Loved Ones, Brain Health Contest, designed to help ... of dementia and Alzheimer,s disease. All five winners will ... designed specifically to help seniors preserve their brain health ... in senior living communities across the country. ...
Breaking Medicine Technology:Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 2Fenwal Responds to New Lawsuit From Haemonetics; Reiterates Commitment to Blood Centers 35 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3New Target May Be Eyed in Kids Brain Cancer 62748 1New Target May Be Eyed in Kids Brain Cancer 62748 2Self Help for the Elderly and the Congress of California Seniors to Announce Expansion of Partnership With Verizon on Dec 8 to Raise Awareness of Eld 62743 1The Countrys Largest Cooking Magazine Announces The Comfort Food Diet Cookbook 62738 1The Countrys Largest Cooking Magazine Announces The Comfort Food Diet Cookbook 62738 2The Countrys Largest Cooking Magazine Announces The Comfort Food Diet Cookbook 62738 3
(Date:12/15/2009)... new electrophoretic method for detecting MIRCERA and other ... using SARCOSYL-PAGE, has specifically enhanced sensitivity for MIRCERA, ... SDS-PAGE for detecting other EPOs. Details of ... World Anti-Doping Agency (WADA), appear in the latest ... published by Wiley-Blackwell. , MIRCERA (methoxy polyethylene glycol-epoetin ...
(Date:12/15/2009)... 15 The failure of the U.S. ... cut costs, much less the more effective direct ... latest example of how big industry controls the ... proposed drug amendment by Senator Dorgan (D-ND) was ... campaign pledge to allow Medicare to directly negotiate ...
(Date:12/15/2009)... 15 SUMMARY: The U.S. ... Protection and Affordable Care Act that would have ... for the safe and legal importation of lower ... by AARP and sponsored by Senators Dorgan, Snowe, ... and helped to bring down the skyrocketing costs ...
(Date:12/15/2009)... State Authority, Ban on Annual Benefit Limits, & ... Consumer Watchdog condemned the removal of ... and the public option from the U.S. Senate ... the Senate must still make three essential fixes ... the entire health care system to the insurance ...
(Date:12/15/2009)... Dec. 15 Senetek PLC (OTC Bulletin Board: SNKTY), a Life Sciences company engaged ... today announced that shareholders had approved all three resolutions that the Company had proposed at ... follows: , , Description of ... Votes ... For ...
Breaking Medicine News(10 mins):Health News:Researchers discover novel method for detecting MIRCERA 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 2Health News:Failure of Drug Importation Amendment in U.S. Senate is Latest Show of Industry's Controlling Hand in Health Reform Debate, According to Consumer Watchdog 3Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 2Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 3Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 4Health News:The 'Big 3' Fixes for the Weakened Senate Health Reform Bill to Block Full Insurance Co. Take-Over of Health System 5Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3
... Hodge / Niederer / Cariani /,Lindsay, a leading, national ... Joyce has joined the San Francisco office. Mr. Joyce,will ... board searches throughout the United States., Mr. Joyce ... accomplishments span a range of complex businesses -- large ...
... WASHINGTON, Dec. 5 A report documenting that,the ... and,underperforming is all the evidence Congress should need ... tobacco regulation to that,overburdened agency., That,s the ... President of,60 Plus, a national senior advocacy organization. ...
... Society of,Hematology (ASH), the world,s largest professional society ... made notable,contributions to the genetic understanding of disease. ... Medal, intended to honor an individual,with a distinguished ... will receive the William Dameshek Prize, awarded to ...
... Dec. 5 - The American Society of,Hematology (ASH) is ... recognition of the important role they play in the ... Edward J. Benz,Jr., MD, and Harold R. Roberts, MD, ... in Atlanta., Each year, two awardees, one from ...
... PHILADELPHIAJehovahs Witness patients no longer have to die for ... and Medical Director of the Center for Bloodless Medicine ... Medicine hospital network. Dr. Ford is one of the ... technique to doctors around the world. , One ...
... pollution, especially diesel exhaust , , WEDNESDAY, Dec. 5 (HealthDay ... health damage done by automotive air pollution, especially the ... of improving air quality in Switzerland, which started with ... benefits in lung function for adults as they aged, ...
Other Medicine News:Health News:Dennis Joyce Joins Executive and Board Search Firm Hodge / Niederer / Cariani / Lindsay 2Health News:Leader Urges Congress Not to Worsen FDA Crisis 2Health News:Top Scientists to Receive Prestigious Awards From the American Society of Hematology 2Health News:Top Scientists to Receive Prestigious Awards From the American Society of Hematology 3Health News:Inspirational Medical Teachers Honored with Mentor Awards from the American Society of Hematology 2Health News:New choices for patients: Transfusion-free medicine for Jehovah's Witnesses and transfusion-wary 2Health News:Cleaner Air Leads to Healthier Lungs 2Health News:Cleaner Air Leads to Healthier Lungs 3
... The Optimal temporary implant for use with ... The pupil dilator type 5S is a ... of the pupil during phacoemulsification. It is ... use. Indication: Expansion of the pupil during ...
... coated with a thin layer ... the surface slick as glass ... prevent debris from collecting on ... For partial stenosis. Silicone with ...
For use with Crawford Intubation Systems....
... as thread-guide reducing time and trauma in ... is inserted into the nasolacrimal duct and ... it. The probe is then withdrawn leaving ... tubing in place. Canalicular Laceration or Imperforate ...
Medicine Products: